Should you buy IBO stock?
Last updated:
Based on market data through , StockInvest.us rates Impact Biomedical Inc. (IBO) as a Sell Candidate with a technical score of -2.91 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Up 0.09%
- 3-month trend forecast Down 25.39%
- Easy Tracking In The Watchlist
Green day on Monday for Impact Biomedical Inc. stock after gaining 0.0919%
(Market data through Aug 10, 2026)
The Impact Biomedical Inc. stock price gained 0.0919% on the last trading day (Monday, 10th Aug 2026), rising from $0.435 to $0.436. During the last trading day the stock fluctuated 6.00% from a day low at $0.415 to a day high of $0.440. The price has risen in 5 of the last 10 days and is up by 0.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 26 thousand shares were bought and sold for approximately $11.43 thousand.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.39% during the next 3 months and, with a 90% probability hold a price between $0.302 and $0.360 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
IBO Signals & Forecast
There are mixed signals in the stock today. The Impact Biomedical Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.437 and $0.457. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 2.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Impact Biomedical Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Impact Biomedical Inc. stock
Impact Biomedical Inc. finds support from accumulated volume at $0.432 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0249 between high and low, or 6.00%. For the last week, the stock has had daily average volatility of 6.56%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (IBO) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Impact Biomedical Inc. to open at $0.430, and during the day (based on 14 day Average True Range), to move between $0.421 and $0.450, which gives a possible trading interval of +/-$0.0297 (+/-7.06%) up or down from last closing price. If Impact Biomedical Inc. takes out the full calculated possible swing range there will be an estimated 7.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.432 (0.80%) than the resistance at $0.460 (5.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Impact Biomedical Inc. stock A Buy?
Impact Biomedical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-2.907
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.430 ( 1.23%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IBO Performance
Trading levels for IBO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.455 | 4.49% |
| R2 | 0.446 | 2.30% |
| R1 | 0.440 | 0.95% |
| Price | 0.436 | |
| S1 | 0.421 | -3.42% |
| S2 | 0.415 | -4.77% |
| S3 | 0.405 | -6.95% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.498 | 14.28% |
| R2 | 0.484 | 11.14% |
| R1 | 0.460 | 5.63% |
| Price | 0.436 | |
| S1 | 0.432 | -0.80% |
| S2 | 0.430 | -1.19% |
| S3 | 0.430 | -1.26% |
FAQ
Click here for our free guide on how to buy Impact Biomedical Inc. Stock.
Buy IBO